Matches in SemOpenAlex for { <https://semopenalex.org/work/W4295037624> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W4295037624 endingPage "11" @default.
- W4295037624 startingPage "1" @default.
- W4295037624 abstract "Payer-addressable burden (PAB) reflects how real-world disease-associated costs impact the per member per month (PMPM) budget of a health plan, and can help to delineate drivers of PMPM costs and inform cost-management strategies for diseases with a high cost burden, such as Crohn’s disease (CD). We aimed to evaluate the U.S. PAB of CD managed with biologics. Weighted mean costs per member with CD in the commercial health plan population between 2017 and 2019 were evaluated from a health plan actuarial perspective. In addition to the overall population of members with CD treated with adalimumab, infliximab, vedolizumab, or ustekinumab, the subpopulations of members who were naive to biologic therapies at treatment initiation and/or treatment-adherent members were also analyzed. Members treated with vedolizumab contributed the lowest PMPM costs. A similar number of members were treated with vedolizumab and ustekinumab, yet PMPM costs associated with ustekinumab were more than double those of vedolizumab. Biologic naivety and treatment adherence drove lower CD-related PMPM costs. The analyses we present here highlight that treatments and patient subgroups with lower PMPM costs are important focus areas for payers in terms of identifying strategies to manage the budget for CD in a U.S. plan population." @default.
- W4295037624 created "2022-09-09" @default.
- W4295037624 creator A5012246295 @default.
- W4295037624 creator A5012344615 @default.
- W4295037624 creator A5031196608 @default.
- W4295037624 creator A5034161092 @default.
- W4295037624 creator A5035383163 @default.
- W4295037624 creator A5036224637 @default.
- W4295037624 creator A5076365579 @default.
- W4295037624 creator A5082039225 @default.
- W4295037624 date "2022-09-09" @default.
- W4295037624 modified "2023-10-18" @default.
- W4295037624 title "Payer-Addressable Burden of Crohn’s Disease in Members Treated with Biologics in the United States: Actuarial Analysis Findings from RAINBOW" @default.
- W4295037624 cites W1979583846 @default.
- W4295037624 cites W2314993909 @default.
- W4295037624 cites W2539630895 @default.
- W4295037624 cites W2559983657 @default.
- W4295037624 cites W2794595980 @default.
- W4295037624 cites W2803278501 @default.
- W4295037624 cites W2946395156 @default.
- W4295037624 cites W2946537104 @default.
- W4295037624 cites W2965504771 @default.
- W4295037624 cites W2967486945 @default.
- W4295037624 cites W2980610915 @default.
- W4295037624 cites W3040547772 @default.
- W4295037624 cites W3165747682 @default.
- W4295037624 doi "https://doi.org/10.1080/10920277.2022.2102041" @default.
- W4295037624 hasPublicationYear "2022" @default.
- W4295037624 type Work @default.
- W4295037624 citedByCount "0" @default.
- W4295037624 crossrefType "journal-article" @default.
- W4295037624 hasAuthorship W4295037624A5012246295 @default.
- W4295037624 hasAuthorship W4295037624A5012344615 @default.
- W4295037624 hasAuthorship W4295037624A5031196608 @default.
- W4295037624 hasAuthorship W4295037624A5034161092 @default.
- W4295037624 hasAuthorship W4295037624A5035383163 @default.
- W4295037624 hasAuthorship W4295037624A5036224637 @default.
- W4295037624 hasAuthorship W4295037624A5076365579 @default.
- W4295037624 hasAuthorship W4295037624A5082039225 @default.
- W4295037624 hasBestOaLocation W42950376241 @default.
- W4295037624 hasConcept C126322002 @default.
- W4295037624 hasConcept C160735492 @default.
- W4295037624 hasConcept C162324750 @default.
- W4295037624 hasConcept C2776207728 @default.
- W4295037624 hasConcept C2777138892 @default.
- W4295037624 hasConcept C2778975655 @default.
- W4295037624 hasConcept C2779134260 @default.
- W4295037624 hasConcept C2779280984 @default.
- W4295037624 hasConcept C2780132546 @default.
- W4295037624 hasConcept C2908647359 @default.
- W4295037624 hasConcept C2992755240 @default.
- W4295037624 hasConcept C50522688 @default.
- W4295037624 hasConcept C512399662 @default.
- W4295037624 hasConcept C71924100 @default.
- W4295037624 hasConcept C99454951 @default.
- W4295037624 hasConceptScore W4295037624C126322002 @default.
- W4295037624 hasConceptScore W4295037624C160735492 @default.
- W4295037624 hasConceptScore W4295037624C162324750 @default.
- W4295037624 hasConceptScore W4295037624C2776207728 @default.
- W4295037624 hasConceptScore W4295037624C2777138892 @default.
- W4295037624 hasConceptScore W4295037624C2778975655 @default.
- W4295037624 hasConceptScore W4295037624C2779134260 @default.
- W4295037624 hasConceptScore W4295037624C2779280984 @default.
- W4295037624 hasConceptScore W4295037624C2780132546 @default.
- W4295037624 hasConceptScore W4295037624C2908647359 @default.
- W4295037624 hasConceptScore W4295037624C2992755240 @default.
- W4295037624 hasConceptScore W4295037624C50522688 @default.
- W4295037624 hasConceptScore W4295037624C512399662 @default.
- W4295037624 hasConceptScore W4295037624C71924100 @default.
- W4295037624 hasConceptScore W4295037624C99454951 @default.
- W4295037624 hasFunder F4320310030 @default.
- W4295037624 hasLocation W42950376241 @default.
- W4295037624 hasOpenAccess W4295037624 @default.
- W4295037624 hasPrimaryLocation W42950376241 @default.
- W4295037624 hasRelatedWork W2414272582 @default.
- W4295037624 hasRelatedWork W2914662974 @default.
- W4295037624 hasRelatedWork W2984488335 @default.
- W4295037624 hasRelatedWork W2989681206 @default.
- W4295037624 hasRelatedWork W2999567714 @default.
- W4295037624 hasRelatedWork W3192675943 @default.
- W4295037624 hasRelatedWork W4295254747 @default.
- W4295037624 hasRelatedWork W4353047497 @default.
- W4295037624 hasRelatedWork W4366831871 @default.
- W4295037624 hasRelatedWork W4381125750 @default.
- W4295037624 isParatext "false" @default.
- W4295037624 isRetracted "false" @default.
- W4295037624 workType "article" @default.